Characterization and impact of non‐canonical WNT signaling on outcomes of urothelial carcinoma
Cancer Medicine · 2024
DOI: 10.1002/cam4.7148 ↗Kurz gefasst
Fachartikel in der Zeitschrift Cancer Medicine, 2024. Verfasst von Margaret Meagher und 13 weiteren Autor:innen. Beteiligte Einrichtung: Department of Urology, UC San Diego School of Medicine, La Jolla, California, USA. Hauptthemen laut MEDLINE: Carcinoma, Transitional Cell, Urinary Bladder Neoplasms. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 26 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).
Abstract (Originalsprache)
Background
Non‐canonical WNT family (WNT5A pathway) signaling via WNT5A through ROR1 and its partner, ROR2 , or Frizzled2 ( FZD2 ) is linked to processes driving tumorigenesis and therapy resistance. We utilized a large dataset of urothelial carcinoma (UC) tumors to characterize non‐canonical WNT signaling through WNT5A , ROR1 , ROR2 , or FZD2 expression.
Methods
NextGen Sequencing of DNA (592 genes or WES)/RNA (WTS) was performed for 4125 UC tumors submitted to Caris Life Sciences. High and low expression of WNT5A , ROR1 , ROR2 , and FZD2 was defined as ≥ top and
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Urology, UC San Diego School of Medicine, La Jolla, California, USA.
- Caris Life Sciences, Phoenix, Arizona, USA.
- Division of Hematology, Oncology, and Transplantation, University of Minnesota, Minnesota, USA.
- Miami Cancer Institute, Miami, Florida, USA.
- Karmanos Cancer Institute, Department of Oncology, Wayne State University School of Medicine, Detroit, Michigan, USA.
- Department of Medicine, UC San Diego School of Medicine, La Jolla, California, USA.
ORCID-Profile: Harris Krause, Alex Farrell, Rana R McKay, Amirali Salmasi
Zitieren
APA
Meagher, M., Krause, H., Elliott, A., Farrell, A., Antonarakis, E. S., Bastos, B., Heath, E. I., Jamieson, C., Stewart, T. F., Bagrodia, A., Nabhan, C., Oberley, M., McKay, R. R., & Salmasi, A. (2024). Characterization and impact of non‐canonical WNT signaling on outcomes of urothelial carcinoma. Cancer Medicine. https://doi.org/10.1002/cam4.7148
Vancouver
Meagher M, Krause H, Elliott A, Farrell A, Antonarakis ES, Bastos B, et al. Characterization and impact of non‐canonical WNT signaling on outcomes of urothelial carcinoma. Cancer Medicine. 2024. doi:10.1002/cam4.7148
BibTeX
@article{Meagher2024,
author = {Meagher, Margaret and Krause, Harris and Elliott, Andrew and Farrell, Alex and Antonarakis, Emmanuel S and Bastos, Bruno and Heath, Elisabeth I and Jamieson, Christina and Stewart, Tyler F and Bagrodia, Aditya and Nabhan, Chadi and Oberley, Matt and McKay, Rana R and Salmasi, Amirali},
title = {Characterization and impact of non‐canonical WNT signaling on outcomes of urothelial carcinoma},
journal = {Cancer Medicine},
year = {2024},
doi = {10.1002/cam4.7148}
}
EUVIMED